A panel of mouse monoclonal antibodies (MAbs) raised against the non-structural glycoprotein NS1 of dengue 2 virus (PR159) was studied for cross-reactivity with the NS1 protein of other dengue virus serotypes and other members of the Flaviviridae using immunoblotting. Most of the 35 anti-NS1 MAbs were found to be specific for dengue 2 virus NS1 (some of which were specific for the native, dimeric form of this protein), but others were found to cross-react within the dengue virus group. This latter group of MAbs, although dominated by MAbs defining a dengue 2 and 4 virus subgroup, also contained some MAbs that were shown to cross-react with both linear (sequential) and conformational epitopes common to the NS1 glycoproteins of all four dengue virus serotypes. Several of these MAbs were also able to cross-react with other flaviviruses, most notably viruses from the Japanese encephalitis antigenic complex. Although crossreactive epitopes were previously demonstrated on this glycoprotein using polyclonal sera from dengue virusinfected animals and human, this is the first report of the isolation of MAbs which define these determinants and which will allow their further analysis.
Antibody responses raised against the structural proteins of one dengue virus serotype may lead to enhanced disease syndromes when patients are subsequently infected with a heterologous serotype of dengue virus. This phenomenon has been implicated in the pathogenesis of the more severe, and potentially life-threatening forms, of dengue fever (Halstead, 1989) which are an increasing problem in many tropical and subtropical countries (Gubler, 1989) . In an attempt to avoid these problems, studies have been undertaken in order to assess the protective capacity of the non-structural proteins. One of these non-structural proteins, identified as both an extracellular (Russell et al., 1970 ) and a membrane-bound (Cardiff & Lund, 1976) protein, was shown to have epitopes common to all four dengue virus serotypes (Russell et al., 1970; Brinton et al. in Brandt, 1988) . This protein was identified as a 48K glycoprotein using SDS-PAGE (Smith & Wright, 1985) , and after nucleotide sequence analysis showed that it was the first t 0000-9863 © 1991 SGM non-structural protein encoded immediately downstream of the structural proteins, it was named NS 1 (Rice et al., 1985) . Further sequence analyses of dengue virus genes (Mason et al., 1987; Mackow et aL, 1987; Hahn et al., 1988; Osatomi & Sumiyoshi, 1990) has shown NS1 to be highly conserved, most notably in the 11 cysteine residues necessary for the complex folding of this protein.
Although experiments using the NS1 glycoproteins of both yellow fever virus and dengue 2 virus showed that active (Schlesinger et al., 1985 (Schlesinger et al., , 1986 (Schlesinger et al., , 1987 and passive (Schlesinger et al., 1985; Gould et al., 1986; Henchal et al., 1988) protection could be provided to animals challenged with homologous virus, no cross-protection was observed in animals challenged with heterologous dengue viruses. Antibody-mediated (complementdependent) target cell lysis was implicated as the method of protection in these experiments, but passive protection was also demonstrated in other experiments irrespective of whether an individual monoclonal antibody (MAb) could fix complement and/or lyse target cells in vitro (Henchal et al., 1988) . In contrast to the monomeric NS1 preparations used in the above experiments, the native form of the NS1 protein was found to exist as a non-covalently linked dimer which was found to be unstable to treatment with heat or low pH (Winkler et al., 1988) . Using immunoaffinity chromatography and high pH elution, the dimeric forms of both the membrane-associated (mNSI) and extracellular (sNS1) species of dengue 2 virus could be obtained and these were found to be both more antigenic and immunogenic than their monomeric equivalents (Falconar & Young, 1991) . These findings may explain why the active protection experiments using acid-eluted preparations of dengue virus NSl provided only partial protection in dengue virus-challenged animals.
Since neither dengue virus group/subgroup crossreactive, sNSl-specific, nor dimeric NSl-specific MAbs have so far been described, the authors used these dimeric preparations of sNSl (dengue type 2 virus, PR159) in order to generate and screen mouse MAbs defining these specificities and allowing further analyses of these epitopes. In this study, we report the generation of a number of dimeric NSl-specific MAbs and also MAbs defining a number of both dengue virus subgroup and dengue virus complex epitopes on the NS1 protein.
Viruses used were grown either in C6/36 cells maintained in L-15/TPB (Leibovitz) medium (Gibco) or in Vero cells maintained in medium 199 (Gibco) each supplemented with 2.5~ foetal calf serum. After incubation for a period of 5 to 12 days, when c.p.e, was observed, both supernatants and cell monolayers were harvested. Polyethylene glycol (PEG) precipitation was used to concentrate both virus and sNS1 from the supernatants and Triton X-100 was used to obtain cell lysates containing mNS1 (see Falconar & Young, 1991) .
In order to generate high antibody responses prior to MAb production, three eight-week-old BALB/c mice were immunized subcutaneously with 10 gg of affinitypurified sNS1 and boosted monthly twice more with the same dose. All of the mice were found to develop high levels of antibodies to this antigen preparation but only weak cross-reactions with the NS1 proteins of the other dengue virus serotypes were noted in Western blots. Final boosts were performed, on the highest responding animals, 3 days before fusion of their spleen cells with the plasmacytoma cell line SP2/0 at a ratio of 10:1 using PEG (Merck 4000) and short post-PEG incubation times (Lane, 1985) . Using this technique, two fusions were performed and each was plated onto five 96-well tissue culture plates (Nunc). Initial screening was performed by ELISA using dimeric sNS1 adsorbed at 50 ng/well and standard peroxidase/o-phenylenediamine (Sigma) detection methodology. From these two fusions 173 ELISApositive wells were obtained and transferred into 24-well plates (Nunc) for subsequent screening for isotype (ELISA), dimer/sNS1 specificity (Western blot) and ability to cross-react within the dengue virus group (dot blot). Isotyping was performed using isotype-specific antibodies (Serotec); both Western and dot blotting methods have been described elsewhere (Young, 1989; Falconar & Young, 1991) . Briefly, in order to screen for dimer/sNS1 specificity, heated (monomers) and nonheated mixtures of PEG-precipitated supernatants (sNS1) and cell lysates (mNS1) were separated by nonreducing preparative SDS-PAGE, proteins were transferred to nitrocellulose membranes and 1.5 mm strips were used in assays with 250 to 500 gl of antibodycontaining supernatant diluted to 1 ml. Dot blot assays were performed using 2 gl samples of PEG precipitates (sNS 1) concentrated from virus culture supernatants by a factor of 50.
Using these techniques, the majority (88~) of the uncloned well supernatants were found to have antibodies which were reactive only with the homologous dengue 2 virus NS1 serotype, possibly explaining why no dengue virus group cross-reactive MAbs raised against this protein have so far been described. The other 12~ of these fusion products appeared to display some ability to cross-react within the dengue virus group. These results therefore reflected the pre-fusion polyclonal response of these animals and, although some authors have noted that immunizations with dengue 2 virus NS 1 in mice lead to high level cross-reactions, we have consistently observed poor cross-reactive responses in mouse strains syngeneic with the plasmacytoma lines used for MAb production (BALB/c : H-2d). In contrast to some fusions using live virus (Gould et al., 1986) , the antibody isotype found in this study was predominantly IgG 1. Although it is possible that live virus may generate a switch to other antibody isotypes, immunizations with live dengue virus have also resulted in a majority of anti-NS1 MAbs being of the IgG1 isotype (Henchal et al., 1987 (Henchal et al., , 1988 . Interestingly, those wells containing antibodies defining dimeric NSl-specific epitopes in this study were all found to be of the IgG2b isotype. None of the 173 uncloned fusion wells were found to contain antibodies which could differentiate between either mNS1 and sNS-1 or the wild-type virus, PR159 and its attenuated derivative, PR159S1.
As with the flavivirus envelope proteins (see Heinz, 1986) , only poor antibody reactions have been observed using 2-mercaptoethanol-reduced samples of the NS1 proteins, suggesting that most of the epitopes on this protein are also maintained by cysteine bridges. In order to ensure that restoration of cysteine bonds did not occur in this study, NS1 samples were reduced and free sulphydryl groups were alkylated with 8 mM-iodacetamide (see Mason et al., 1989) before dot blot assays were performed. Using this method, a number of the antibody-containing supernatants used in this study were able to define linear (sequential) determinants on the NS1 protein of dengue 2 virus. Dimer -
Monomer -
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6 7 8 Fig. 1 . Immunoblot reaction patterns of dengue 2 virus NSl-specific mouse MAbs. Affinity-purified dimeric NS1 from PR159 was left unheated (dimeric form lanes 1 and 3) or heated in order to produce the monomeric form of the protein, either in the presence (lanes 6 and 8) or absence (lanes 2, 4, 5 and 7) of the reducing agent 2-mercaptoethanol. Immunoblot strips were then processed using three different mouse MAbs: 5HI0.3d (lanes 1 and 2), 5D7.3 (lanes 3, 4, 5 and 6) and 1H7.4 (lanes 7 and 8). The arrowhead identifies sNS1 and the arrow identifies mNS1.
From the 173 uncloned wells, a group representing a number of different specificities/characteristics was selected for cloning by limited dilution (twice) to yield a panel of 35 stable MAb-secreting lines. Each of these MAbs was then obtained in high concentration by injecting the hybridoma cells into pristane-primed mice for ascites production.
Using this panel of 35 MAbs, three distinct reactivities were observed in immunoblots with dengue 2 virus NS1 following either reduction with 2-mercaptoethanol and/ or heat treatment of the protein. Representative profiles of these reactions are shown in Fig. 1 . These categories were found to contain epitopes defining conformationdependent dimer specificity (Fig. 1, lanes 1 and 2) , which nevertheless were present on both monomeric and dimeric NS1 (Fig. 1, lanes 3 to 6) , and linear (sequential) specificity based on MAb reactivity with both heattreated and reduced NS1 (Fig. 1, lanes 7 and 8) . Since dimer specificity, in these experiments, may simply have been a consequence of heat denaturation (used in order to generate the monomer forms), the MAbs defining these epitopes were also tested for their ability to recognize acid (pH 2.5)-generated monomeric forms of these proteins. The finding that those MAbs defining dimer-specific epitopes did not react with low pH (nonheat)-generated monomers suggested true dimer specificity (data not shown).
The panel of 35 MAbs was tested by immunoblotting against 23 dengue 2 virus isolates representing different geographical topotypes and three virus groups were defined based on their reactions with the NS1 glycoprotein (see Table 1 ). The 1954 Trinidad dengue 2 virus isolate, TR1751, was found to be unique amongst these viruses in agreement with previous RNA fingerprint studies (Trent et al., 1983) . Eleven of the MAbs used in this study were unable to react with the NS 1 glycoprotein of this strain in immunoblots. Although the NS1 sequence of PR 159S 1 (Hahn et al., 1988) has been shown to be very different at the amino acid level to other isolates from Jamaica (Deubel et al., 1988) , New Guinea (Irie et al., 1989) , Malaysia (Fong et al., 1990) , Thailand and Sri Lanka (Blok et al., 1991) , only one MAb (5H10.3d) in this panel showed strain specificity. Interestingly, 5H10.3d was found to react only with the Puerto Rican dengue 2 virus isolate, PR159 (and its attenuated derivative, PR159S1) which was used to raise this MAb, and a 1987 Taiwan isolate of dengue 2 virus. In contrast, the other two dimer-specific MAbs, 1G5.4d and 1 B6.4d were found to react with the NS 1 glycoproteins of all 23 isolates. These results suggest that at least two dimer-specific epitopes are present on the protein.
Using Western blotting, and thereby avoiding ambiguous results with weak cross-reactions obtained using dot blots, the panel was tested for ability to crossreact with the NSI proteins of each of the four dengue virus prototypes and representative members of the recently reassigned flavivirus antigenic groups (Calisher et al., 1989) , which were previously designated antigenic groups I to VIII and unknown (U) (de Madrid & Porterfield, 1974; Brinton, 1986) . Since the envelope (E) glycoproteins were known to contain common flavivirus epitopes, a human serum obtained from a dengue fever patient (containing a high antibody titre against this protein) was used in order to ensure that each of the viruses had grown. Using this approach, only the preparation of Bouboui virus (group VI) was found to contain a low level of the E protein and therefore this preparation was also assumed to have a low concentration of NS1. Taking into account reaction patterns with the 23 dengue 2 virus isolates, cross-reactions within the dengue virus group, cross-reactions with other flavivirus groups and the ability to react with linear epitopes, the panel of MAbs could be classified into 14 or 15 different groups (see Table 1 ).
Although one MAb, defining a linear epitope common to the NSI proteins of both dengue 2 and Japanese encephalitis virus, was described previously (Henchal et al., 1987; Putnak et al., 1988) , none of the MAbs in this panel showed similar specificity.
A number of MAbs were able to define both dengue virus serotypes 2 and 4 subgroup (conformational) and dengue virus group (conformational and linear) epitopes on this protein, in support of previous studies using polyclonal sera. In particular, those MAbs defining these dengue virus group/subgroup epitopes were also found to cross-react with members of other flavivirus antigenic Table 1 . 1977 , Tahiti 1975 , Fiji 1971 , New Britain, Kuala Lumpur R982, Singapore, Vietnam, Manila 1974 , Puerto Rico VL69A and New Guinea-C (prototype). Dengue virus 2 group B: Puerto Rico PR159, Puerto Rico PR159S1 (attenuated) and Taiwan :~ Dimer NSl-specific: § + to + + + + indicates the intensity of the immunoblot colour reaction.
Immunoblot cross-reactivity of NSl-specific MAbs with members of the different flavivirus antigenic groups
[I Human anti-dengue 2 virus serum (predominantly anti-E).
groups, most notably group III and some viruses assigned to the U antigenic group. Interestingly, sera obtained from a rabbit previously hyperimmunized with dimeric dengue 2 virus (PR159) sNSI was found to show a crossreaction profile similar to that obtained with this panel of mouse MAbs. Because of the potential vaccine application of cross-reactive epitopes on this protein, these MAbs are now being tested for their ability to provide passive protection against lethal challenge with each of the four dengue virus serotypes. In addition, the location of epitopes defined by this panel of MAbs is being undertaken using a nested set of synthetic peptides covering the entire NS 1 protein of dengue 2 virus (PR 159).
